Colossal Foundation has secured another $50 million, doubling its capital to $100 million a little over a year after launch. The nonprofit reports more than a dozen projects across six continents with 50+ conservation, Indigenous, and academic partners, piloting 20+ new technologies for species protection. New funds will accelerate work on BioVault biobanking, genetic-rescue research, wildlife monitoring, and rewilding—building on first-year milestones such as support for red-wolf recovery, EEHV vaccine advances for elephants, AI bioacoustics in Yellowstone, disease-resistant amphibian R&D, and tools to protect Australia’s quolls from cane toads. Leadership frames the effort as closing a global conservation funding gap while pairing innovation with on-the-ground impact.
Read the full feature on DMagazine.